// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone
USP Principal Scientific Liaison Margareth Marques, Ph.D., provides answers to questi
By: Trish Li and Edith Chang